AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 49 filers reported holding AC IMMUNE SA in Q4 2021. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $355,079 | -3.6% | 124,589 | 0.0% | 0.03% | -3.2% |
Q2 2023 | $368,160 | +26.3% | 124,589 | 0.0% | 0.03% | +55.0% |
Q1 2023 | $291,538 | +14.7% | 124,589 | 0.0% | 0.02% | -9.1% |
Q4 2022 | $254,162 | -35.4% | 124,589 | 0.0% | 0.02% | -35.3% |
Q3 2022 | $393,701 | -12.5% | 124,589 | 0.0% | 0.03% | +6.2% |
Q2 2022 | $449,766 | -9.8% | 124,589 | 0.0% | 0.03% | -15.8% |
Q1 2022 | $498,356 | -34.4% | 124,589 | -18.8% | 0.04% | -22.4% |
Q4 2021 | $759,231 | -49.0% | 153,380 | -30.8% | 0.05% | -52.4% |
Q3 2021 | $1,487,936 | – | 221,749 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 7,428,379 | $21,170,880 | 0.57% |
Avidity Partners Management LP | 2,969,800 | $8,463,930 | 0.34% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,322,462 | $3,769,017 | 0.15% |
Eversept Partners, LP | 124,589 | $355,079 | 0.03% |
COHEN LAWRENCE B | 12,850 | $36,623 | 0.02% |
Banque Cantonale Vaudoise | 80,701 | $231 | 0.01% |
Renaissance Technologies | 425,179 | $1,212 | 0.00% |
Handelsbanken Fonder AB | 101,064 | $288 | 0.00% |
Tower Research Capital LLC (TRC) | 19,638 | $55,968 | 0.00% |
Compagnie Lombard Odier SCmA | 10,000 | $28,500 | 0.00% |